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Background: Preoperative risk stratification models have previously been suggested to predict cardiac surgery unit
costs. However, there is a lack of consistency in their reliability in this field. In this study we aim to test the
correlation between the values of six commonly known preoperative scoring systems and evaluate their reliability
at predicting unit costs of cardiac surgery patients.
Methods: Over a period of 14 months all consecutive adult patients undergoing cardiac surgery on
cardiopulmonary bypass were prospectively classified using six preoperative scoring models (EuroSCORE, Parsonnet,
Ontario, French, Pons and CABDEAL). Transplantation patients were the only patients we excluded. Total hospital
costs for each patient were calculated independently on a daily basis using the bottom up method. The full unit
costs were calculated including preoperative diagnostic tests, operating room cost, disposable materials, drugs,
blood components as well as costs for personnel and fixed hospital costs. The correlation between hospital cost
and the six models was determined by linear regression analysis. Both Spearman’s and Pearson’s correlation
coefficients were calculated from the regression lines. An analysis of residuals was performed to determine the
quality of the regression.
Results: A total of 887 patients were operated on for CABG (n = 608), valve (n = 142), CABG plus valve (n = 100),
thoracic aorta (n = 33) and ventricular assist devices (n = 4). Mean age of the patients was 68.3±9.9 years, 27.6%
were female. 30-day mortality rate was 4.1%. Correlation between the six models and hospital cost was weak
(Pearson’s: r < 0.30; Spearman’s: r < 0.40).
Conclusion: The risk stratification models in this study are not reliable at predicting total costs of cardiac surgical
patients. We therefore do not recommend their use for this purpose.
Keywords: Hospital cost, Cardiac surgery, Scoring modelsBackground
Preoperative risk stratification scoring models have been
used to predict mortality after heart surgery [1]. Several
studies have suggested that these models can be used to
predict the total cost of cardiac surgical patients [2-7].
An admission scoring model that can accurately predict
an estimate of patients’ cost would facilitate allocation of
resources as well as the planning of more economical
patient care. As these models were originally designated
for the sole purpose of predicting mortality we find their
use to predict events other than mortality (e.g. morbidity
or hospital cost) questionable. Hence, we reviewed the* Correspondence: khosro.hekmat@uk-koeln.de
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reproduction in any medium, provided the orliterature searching for previous studies that investigated
the correlation between preoperative cardiac surgical sco-
ring models and total hospital costs. We then conducted a
prospective study to evaluate these scoring systems as a
predictor of total hospital costs in open heart surgery. The
six models we evaluated were: EuroSCORE, Parsonnet,
Ontario, French, Pons and CABDEAL.Methods
Risk factors for all consecutive adult patients undergoing
open heart surgery in the department of Cardiothoracic
Surgery at the University of Cologne, over a period of
14 months, were prospectively collected. The patients’
records contained all variables necessary to match the
criteria for all six risk stratification scoring systems:ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Preoperative patient characteristics of the study
population
Patients data All patients (n = 887)
Age (years) 68.28 ±9.85
Female 27.6%
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[11], Pons [12], and CABDEAL [13]. We have used the
additive EuroSCORE and not the logistic EuroSCORE,
to keep it consistent with the other models.
All information required was collected on patient
admission and were documented in the quality control
system QIMS 2.0b (University hospital of Muenster,
Germany). Relevant laboratory data were collected elec-
tronically from the central laboratories and were inte-
grated in the QIMS 2.0b system. The attending
physicians collected the data and checked for accuracy.
The data collection and calculations of the scoring sys-
tems were validated by both a medical clerk and a senior
supervisor.
Total hospital costs were calculated on a daily basis
for each patient using the bottom up method. All costs
were calculated including preoperative diagnostic tests,
operating room costs, disposables, drugs, blood compo-
nents as well as costs for personnel, and hospital-fixed
costs, according to the “Manual for calculating patient
costs; Version 3.0” published in the year 2007 by the
German Hospital Federation (DKG) and the German in-
surance companies (GKV and PKV).
No experimental research was conducted for this study
neither on humans nor on animals. All data were mea-
sured within the limits of a routine ICU admission of
each individual patient. Therefore an ethical approval
was not necessary.Weight (kg) 80.55 ± 13.33
Height (cm) 171.47 ±8.48
Hypertension 82,60%
Ejection Fraction (<50%) 8.0%






Recent myocardial infarction (< 90 days) 26.2%
Preoperative cardiac massage 2.0%Statistical methods
Statistical analyses were performed using SPSS software
version 18 (SPSS Inc, Chicago, IL, USA). Continuous
scale data are presented as mean ± standard deviation
(SD) and were analyzed by the Kolmogorov–Smirnov
test for normal distribution. A p-value < 0.05 was consi-
dered significant for all tests.
Linear regression analysis was used to determine the
correlation between costs and the six risk stratifications
models. Both Pearson’s and Spearman’s correlation coef-
ficients were calculated from the regression line. An ana-
lysis of residuals was performed to determine the quality
of the regression.Extracardiac arteriopathy 7.80%
Ventricular tachycardia or fibrillation 2.0%
Chronic Obstructive Pulmonary Disease 10.4%
Preoperative ventilation 1.6%
Creatinine > 1.6 mmol/l 10.30%
Acute renal failure 2.80%
Focal neurological deficit 11.3%
Diabetes mellitus 27.50%
Sepsis 0.20%
Previous cardiac surgery 3.2%Pearson’s correlation
The Pearson’s correlation coefficient (r) measures the
linear association between two scale variables (in this
study, the score points and the total hospital cost). A
perfect positive (increasing) linear correlation is repre-
sented by +1 and a perfect negative decreasing linear re-
lationship is represented by −1 [14]. As values approach
zero there is less correlation and zero represents no cor-
relation. Generally, correlations above 0.80 are consi-
dered high.Furthermore, the t-test is used to establish if the cor-
relation coefficient is significantly different from zero,
and, hence that there is evidence of an association be-
tween the two variables. This means that, when the
p-value of Pearson’s test is significant, this indicates only
that there is merely a linear relation between both varia-
bles. But this significance does not indicate if this relation
(correlation) is high or low. This p-value is influenced by
the sample size; however, with larger sample sizes the
strength of the correlation weakens.
The normal distribution of the data in both variables
is a prerequisite for Pearson’s test. If this is not the case,
the conclusions may well be invalidated. Accordingly, it
is better to use Spearman’s coefficient.
Spearman’s correlation
Rank correlation coefficients, such as Spearman’s mea-
sures the extent to which, as one variable increases, the
other variable tends to increase or decreases, without
requiring that this association is a linear relationship.
Spearman’s test is an alternative test to Pearson’s to
make the coefficient less sensitive to non-normality in





Additive EuroSCORE 7.12 3.19 0 20
Cabdeal 2.65 1.77 0 9
French 6.07 3.65 0 26
Parsonnet 13.64 8.03 0 42
Ontario 5.22 2.57 0 14
Pons 9.73 9.05 0 42
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measure of a different type of association, rather than as
alternative measure [15,16].
Unlike Pearson’s correlation, Spearman’s correlation
indicates that as the value of one variable (score model
in this study) changes, there is always a change in the
value of the other variable (total hospital cost), when
there is a perfect rank correlation. On the other hand,
Pearson’s correlation is perfect when the increase in the
first variable is accompanied with an equal change (in-
crease or decrease) in the other variable. Accordingly, a
good Spearman’s correlation does not necessarily mean
a good Pearson’s correlation as well. Hence, the values
of the two coefficients cannot meaningfully be compared
[15].Results
A total of 887 patients were operated on with cardiopul-
monary bypass. Preoperative characteristics are listed in
Table 1. Mean age of the patients was 68.3 ± 9.9 years,
27.6% were female. Table 2 shows the mean values of
preoperative scoring models upon admission. For the
whole study population, length of stay in intensive care
unit (ICU) was 88.5 ± 148.8 hours (median was 49 hours
range was 14–1776 hours), hospital-stay was 16.7 ± 8.9
days and the 30-day mortality rate was 4.1%. Table 3
demonstrates the ICU-stay, hospital-stay and 30 day
mortality for each operative procedure separately.
Table 4 shows the total hospital costs and the reim-
bursement for the different operative procedures. The
reimbursement covered and exceeded the total costs inTable 3 Data of different operative procedures performed du
Procedure n (%) ICU-stay (hours)
CABG 608 (68.55) 71.3 ± 124.3
Valve surgery 142 (16.01) 83.2 ± 92.0
CABG + Valve 100 (11.27) 134.8 ± 198.4
Aortic surgery 33 (3.72) 255.7 ± 320.9
VAD 4 (0.45) 359.0 ± 280.0
Total 887 (100) 88.5 ± 148.8all procedures except in the VAD group, in which the re-
imbursement covered less than 60% of the cost.
The correlation of all preoperative scoring models with
the total hospital cost was weak with correlation coeffi-
cients ranging between 0.122 and 0.264, according to
Pearson’s test and between 0.122 and 0.372, according to
Spearman’s test. This is despite a significant difference
from zero in both tests with a p-value < 0.01 all through
in both tests, except for the correlation of CABDEAL
score with the reimbursement, which was not different
from zero (uncorrelated) with p = 0.05.
Discussion
Statement of key findings
The purpose of this study was to evaluate whether the
six preoperative risk stratification models can predict
total hospital costs in cardiac surgical patients. The re-
sults show that all of these models have low correlation
with total hospital cost and reimbursement (r < 0.4).
Results of previous studies
Several studies concluded that preoperative risk stratifi-
cation models, initially designed to predict mortality, are
also useful for predicting resource utilization in cardiac
surgical patients [2-7]. Haehnel et al. [2] suggested that
the Cleveland score predicts costs in cardiac surgery.
Unfortunately this paper shows this finding graphically
only, without giving a correlation coefficient or a p-value.
Kurki et al. [3] also evaluated the relationship between the
Cleveland score and hospital costs. Again, no information
about the correlation value was provided.
Recent studies with the EuroSCORE found a direct
correlation between this risk model and hospital cost
[5-7]. The p-values of the linear regression analysis
were highly significant in all three studies (p < 0.0001).
The correlation coefficients were r = 0.43 in the study of
Sokolovic et al. [5] and r = 0.47 in both studies from
Pinna Pintor et al. [6] and Nilsson et al. [7]. From a stat-
istical point of view only coefficients r > 0.8 are an indi-
cator of a good correlation [17]. A significant p-value
means only, that the regression line is significantly dif-
ferent from a slope of zero. Figure 1 shows the Pearson’s
correlation of EuroSCORE with total hospital cost, which
demonstrates, that there is only a low correlation betweenring the study period
Hospital-stay (days) 30-day mortality (%)
15.5 ± 7.9 3.10
15.8 ± 6.7 3.50
18.6 ± 15.4 9.0
19.97 ± 10.4 9.10
22.75 ± 11.7 0.0
16.7 ± 8.9 4.1
Table 4 Values of total hospital cost and reimbursement in Euro for different operative procedures
Procedure Total cost Costs per patient Total reimbursement Reimbursement per patient
CABG 6,542,864.32 10,761.29 ± 6,319.15 7,873,216.96 12,949.37 ± 6,922.07
Valve 1,992,313.96 14,030.38 ± 5,211.57 2,426,718.94 17,089.57 ± 6,635.17
CABG + Valve 1,744,030.0 17,440.30 ± 11,261.86 1,945,560.0 19,455.60 ± 9,502.96
Aortic surgery 789,729.27 23,931.19 ± 16,721.23 846,656.58 25,656.26 ± 20,727.58
VAD 330,178.6 82,544.65 ± 15,885.09 187,413.50 46,853.25 ± 37,305.62
Total 11,399,111.97 12,851.31 ± 9,428.97 13,304,405.71 14,999.33 ± 9,292.13
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ever, the regression line is significantly different from the
zero value (p = 0.0001). To clarify this difference, we dem-
onstrate in Figure 2 the Pearson’s correlation between the
length of ICU stay and the total hospital cost. As expected,
there is a good correlation between hospital costs and
length of ICU stay (r = 0.94), with p < 0.01 as it is with
EuroSCORE. The difference between both regression lines
is obvious despite the same p-value in both cases.
Moreover, both Pinna Pintor et al. [6] and Nilsson
et al. [7] used a log transformation of the dependent
variable (hospital cost) in order to measure the relation-
ship between EuroSCORE and hospital costs. The ad-
vantage of this transformation is that the influence of



























Figure 1 Linear regression for the EuroSCORE with hospital costs (n =better. This procedure gives an inflated sense of de-
pendence of the hospital costs on the predictor varia-
ble (EuroSCORE) [18].
To our knowledge the only study with a high correlation
coefficient was published by Kurki et al. [4] in 2002. They
reported the correlation between the CABDEAL scoring
system and hospital cost to be almost linear with a coeffi-
cient of r = 0.85 and a p-value < 0.0001. Unfortunately, this
study has several limitations: First, the study of Kurki et al.
[4] has a retrospective design. Secondly, three variables
(arrhythmia, body mass index and creatinine) of a total of
seven variables in the CABDEAL score were not con-
stantly documented in the 30 different hospitals involved.
Also, the hospital costs were calculated from hospital
charge data. This so called “top-down” method divides the10 15 20
roSCORE
r = 0.23                             
p = 0.0001                      
y=  11722 + 232 x
877).
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Figure 2 Linear regression for ICU length of stay with hospital costs (n = 877).
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per patient. This is a simple method but has the disadvan-
tage of being inaccurate at individual patient level. In our
study we used the “bottom-up” approach, which is more
time consuming but more reliable, as resource costs are
added up from individual items of care [19]. Accordingly,
we found the CABDEAL score to be associated with
the worst correlation (see Tables 5 and 6) of all scores
investigated.
Ferraris et al. [20] found a poor correlation between
the New York State risk model and hospital costs. A
similar finding was reported by Riordan et al. [21], whoTable 5 Correlation of scoring models with total hospital
cost
Score r (Pearson) p (Pearson) r (Spearman) p (Spearman)
Additive
EuroSCORE
0.225 < 0.01 0.254 < 0.01
Cabdeal 0.122 < 0.01 0.122 < 0.01
French 0.250 < 0.01 0.237 < 0.01
Parsonnet 0.149 < 0.01 0.296 < 0.01
Ontario 0.256 < 0.01 0.372 < 0.01
Pons 0.264 < 0.01 0.345 < 0.01demonstrated that the STS model is a poor predictor of
costs on an individual patient level. The correlation co-
efficient in this study was r = 0.34. Both studies were
confirmed by our data although we used different risk
stratification models.
Length of ICU-stay and total costs
All studies mentioned above [2-7,20,21] showed a good
relationship between hospital costs and length of stay
in the ICU, which was also confirmed by our study
(r = 0.94, p = 0.0001, Figure 2). Time in the operating
room (OR) is the most expensive part of hospitalization,Table 6 Correlation of scoring models with
reimbursement
Score r (Pearson) p (Pearson) r (Spearman) p (Spearman)
Additive
EuroSCORE
0.133 < 0.01 0.111 < 0.01
Cabdeal 0.075 0.05 0.023 0.05
French 0.152 < 0.01 0.13 < 0.01
Parsonnet 0.102 < 0.01 0.176 < 0.01
Ontario 0.172 < 0.01 0.256 < 0.01
Pons 0.185 < 0.01 0.228 < 0.01
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The second most expensive stay is in the ICU which
highly variable in this study (range was 14 – 1776
hours). Therefore, total hospital costs are likely to be
correlated mainly with the ICU length of stay. The pre-
operative hospitalization and non-ICU portion of the
convalescence are much less expensive. However, this
correlation between total cost and ICU length of stay
can be calculated only after ICU discharge, which does
not help the allocation of resources upon admission.
The cost of a non-fatal complication due to cardiac
surgery is difficult to predict with existing models for
risk-assessment. This may be because the models were
designed to predict death rather than costs of morbid
events. Also patients with complications do not neces-
sarily have longer admission times, which introduce con-
siderable variability when attempting to predict hospital
cost from preoperative risk-assessment data. The failure
of the six risk models tested in predicting costs is not
surprising, since they were designed to predict mortality
[10-13,22,23]. Thus, development of more accurate mor-
bidity scores may be an option to achieve appropriate fi-
nancial risk models.Conclusion
All six preoperative scoring models evaluated here fail to
accurately predict the total costs of a cardiac surgery pa-
tient. Reconsidering the variable of these scores and
their additive weight regarding the total hospital cost as
an outcome is recommended to produce a reliable finan-
cial risk model.Consent
Written informed consent was not obtained from the
patients for publication of this report or any accompa-
nying images, since we report of a large population not
about an individual patient. No image of an individual
patient is accompanied.
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